A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer, reducing death risk by over 40%. The study followed more than 1,000 ...
Scientists have developed a fully human antibody that halted the growth and spread of aggressive prostate cancer in preclinical research. Although more testing is needed, the drug’s unusual mechanism ...
The Hearty Soul on MSN
Many older men are taking a prostate drug they no longer need
New research in JAMA Network Open finds 1 in 3 older men experience no benefit from tamsulosin The post 1 in 3 Older Men on ...
Add Yahoo as a preferred source to see more of our stories on Google. ‘Remarkable’ results in study on new prostate cancer drug A drug for advanced prostate cancer has shown "remarkable" results in an ...
A newly expanded prostate cancer drug could bring new hope to patients with a common form of the disease. Novartis, a Switzerland-based pharmaceutical company, announced on March 28 that the U.S. Food ...
Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%. The trial results ...
Hosted on MSN
ASCO 2026: A major prostate cancer trial shows drug can keep high-risk disease from returning for longer
For men diagnosed with high-risk prostate cancer, surgery is often part of the treatment plan, but nearly half of all patients who undergo radical prostatectomy for high-risk disease will see their ...
Add Yahoo as a preferred source to see more of our stories on Google. Hormonal changes in a man's aging body can cause the prostate to grow—resulting in urinary problems since the gland is wrapped ...
Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute myeloid leukemia (AML), according to a new study by researchers at Penn ...
Johnson & Johnson is adding to its oncology pipeline with a $3.05 billion deal to acquire Halda Therapeutics, a startup whose first-in-class approach to prostate cancer could overcome drug resistance ...
Naki, a Cavalier King Charles dog, undergoes a scanning process for cancer check, at the Maison-Alfort veterinary Hospital in Maison-Alfort, southeast of Paris on June 9, 2026. At the Maisons-Alfort ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results